Zoekresultaten - 6 results

Screening for nanoparticles in complex matrices within a regulatory framework: are we there yet?

coating of confectionery, for decoration of chocolates, and in liqueurs. It is commercially distributed in its pristine powder and sheet form, and in confectionary products. The presented work is part of ...

Appoaching EMA and National regulatory authorties: who, when and how.

Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: 2017 Vaccines Bioprocess Development & Commercialization Workshop, MIT Center for Biomedical ...

Panel discussion on CMC for vaccines: "Responding in Time: Dealing with Predictable and Unpredictable"

Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: 2017 Vaccines Bioprocess Development & Commercialization Workshop, MIT Center for Biomedical ...

Occurrence of polybrominated diphenyl ethers and emerging halogenated flame retardants in food items

a wide range of commercial and household products in order to reduce their flammability. Because most BFR s are not chemically bonded to the products which they are added to, they can easily leach into the ...

Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mind-set of the manufacturer.

between the intention of putting a vaccine on the market and the first available commercial batch, aside from the development of the product and the Marketing Authorization (MA) process. Since OCABR in EU ...

Biological activity conferred by endocrine disrupting chemicals in hospital effluent and river water from the Brussels Region, Belgium

hospital effluent and, respectively, 52.3 and 1.2ng EEQ /L for WWTP influent and effluent. For comparison reasons, commercial drinking waters amount to 0.004-0.070 ng EEQ /L. These results indicate that ...

QR code

QR code for this page URL